Cargando…

The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†

AIMS: Plasma levels of apolipoprotein B (apoB), the main surface protein on LDL particles, and LDL-C, the amount of cholesterol in those particles, are closely correlated and, considered separately, are positive risk factors. Plasma levels of apolipoprotein A(1), the main surface protein on HDL part...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parish, Sarah, Peto, Richard, Palmer, Alison, Clarke, Robert, Lewington, Sarah, Offer, Alison, Whitlock, Gary, Clark, Sarah, Youngman, Linda, Sleight, Peter, Collins, Rory
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735728/ https://www.ncbi.nlm.nih.gov/pubmed/19520708 http://dx.doi.org/10.1093/eurheartj/ehp221

Ejemplares similares

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
por: Yun, Yeo-Min
Publicado: (2023)

Associations of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B With Cardiovascular Disease Occurrence in Adults: Korean Genome and Epidemiology Study
por: Yun, Shin Young, et al.
Publicado: (2023)

Discordance between apolipoprotein B or non-HDL-cholesterol and LDL-cholesterol in middle-aged and elderly Chinese patients predicts arterial stiffness
por: Qu, Geyue, et al.
Publicado: (2021)

Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia
por: Farnier, Michel, et al.
Publicado: (2014)

Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes
por: Brinton, Eliot A., et al.
Publicado: (2016)

β-COP as a Component of Transport Vesicles for HDL Apolipoprotein-Mediated Cholesterol Exocytosis
por: Ma, Weilie, et al.
Publicado: (2016)

Prevalence and Impact of Apolipoprotein E7 on LDL Cholesterol Among Patients With Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2021)

The effects of serum cholesterol, LDL, and HDL levels on gallstone cholesterol concentration
por: Atamanalp, S. Selcuk, et al.
Publicado: (2013)

Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides
por: Higashi, Yukihito
Publicado: (2023)

The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs
por: Silbernagel, Günther, et al.
Publicado: (2022)

Discordance of Apolipoprotein B, Non-HDL-Cholesterol, and LDL-Cholesterol Predicts Risk of Increased Arterial Stiffness and Elevated Carotid Intima-Media Thickness in Middle-Aged and Elderly Chinese Adults
por: Jia, Xiaojing, et al.
Publicado: (2022)

The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee
por: Strandhagen, Elisabeth, et al.
Publicado: (2004)

Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein
por: Corsetti, James P., et al.
Publicado: (2012)

Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites
por: Martin, Seth S., et al.
Publicado: (2009)

Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol
por: Briers, Pieter-Jan, et al.
Publicado: (2021)

ApoB and Non‐HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke Risk
por: Johannesen, Camilla D. L., et al.
Publicado: (2022)

Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study
por: Parish, Sarah, et al.
Publicado: (2018)

Non-HDL-cholesterol as valid surrogate to apolipoprotein B(100 )measurement in diabetes: Discriminant Ratio and unbiased equivalence
por: Hermans, Michel P, et al.
Publicado: (2011)

Cholesterol Determines and Limits rHDL Formation from Human Plasma Apolipoprotein A-II and Phospholipid Membranes
por: Bassett, G. Randall, et al.
Publicado: (2012)

Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease
por: Jensen, Majken K., et al.
Publicado: (2012)

Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease
por: Du, Tingting, et al.
Publicado: (2017)

Increased apolipoprotein M induced by lack of scavenger receptor BI is not activated via HDL-mediated cholesterol uptake in hepatocytes
por: Feng, Yue-Hua, et al.
Publicado: (2018)

Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection
por: Hilser, James R., et al.
Publicado: (2021)

Increased Glycation and Oxidative Damage to Apolipoprotein B100 of LDL Cholesterol in Patients With Type 2 Diabetes and Effect of Metformin
por: Rabbani, Naila, et al.
Publicado: (2010)

Long-term orange juice consumption is associated with low LDL-cholesterol and apolipoprotein B in normal and moderately hypercholesterolemic subjects
por: Aptekmann, Nancy P, et al.
Publicado: (2013)

The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol
por: Bouter, Kristien E. C., et al.
Publicado: (2020)

The Effects of Apolipoprotein F Deficiency on High Density Lipoprotein Cholesterol Metabolism in Mice
por: Lagor, William R., et al.
Publicado: (2012)

Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque Regression
por: Masson, Walter, et al.
Publicado: (2015)

Guanosine effect on cholesterol efflux and apolipoprotein E expression in astrocytes
por: Ballerini, Patrizia, et al.
Publicado: (2006)

Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population
por: Nantsupawat, Nopakoon, et al.
Publicado: (2019)

Non-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDL Cholesterol in Japanese Subjects with TG Levels <400 mg/dL
por: Moriyama, Kengo, et al.
Publicado: (2016)

Association of the Apolipoprotein B/Apolipoprotein A-I Ratio, Metabolic Syndrome Components, Total Cholesterol, and Low-Density Lipoprotein Cholesterol with Insulin Resistance in the Population of Georgia
por: Makaridze, Zaza, et al.
Publicado: (2014)

Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II
por: Melchior, John T., et al.
Publicado: (2021)

Rare primary dyslipidaemias associated with low LDL and HDL cholesterol values in Portugal
por: Alves, Ana Catarina, et al.
Publicado: (2023)

Lymphotoxin-α Gene and Risk of Myocardial Infarction in 6,928 Cases and 2,712 Controls in the ISIS Case-Control Study
por: Clarke, Robert, et al.
Publicado: (2006)

Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
por: Santana, Monique F. M., et al.
Publicado: (2020)

Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity
por: Bobin-Dubigeon, Christine, et al.
Publicado: (2022)

Apolipoprotein Signature of HDL and LDL from Atherosclerotic Patients in Relation with Carotid Plaque Typology: A Preliminary Report
por: Finamore, Francesco, et al.
Publicado: (2021)

Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan
por: Nurtazina, Alma, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_krp0thtmndg7c28njmvs66sg7s